The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
Myocardial infarction (MI) is a devastating disease with high morbidity and mortality caused by the irreversible loss of functional cardiomyocytes and heart failure (HF) due to the restricted blood supply. Mesenchymal stem cells (MSCs) have been emerging as lead candidates to treat MI and subsequent...
Saved in:
| Main Authors: | Xianyun Wang, Yida Tang, Zhao Liu, Yajuan Yin, Quanhai Li, Gang Liu, Baoyong Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2021/5579904 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
by: Shujing Li, et al.
Published: (2016-01-01) -
Exosomes derived from TNF-α-treated bone marrow mesenchymal stem cells ameliorate myocardial infarction injury in mice
by: Shuo Wang, et al.
Published: (2024-12-01) -
Therapeutic potential of exosomes derived from human endometrial mesenchymal stem cells for heart tissue regeneration after myocardial infarction
by: Masoumeh Sepehri, et al.
Published: (2025-03-01) -
Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction
by: Sha Zhongxin, et al.
Published: (2025-07-01) -
Advances in application of hypoxia-preconditioned mesenchymal stem cell-derived exosomes
by: Haitao Zhuo, et al.
Published: (2024-08-01)